Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Caris Life Sciences, Inc. publishes a filing, an earnings call transcript or a press release.

Get CAI alerts

About Luke Power

Luke Power is recorded as CFO at Caris Life Sciences, Inc. (CAI). Luke Power has spoken on 4 earnings calls and 2 other investor events across 1 company, most recently for Caris Life Sciences, Inc. on November 4, 2026. Caris Life Sciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Caris Life Sciences, Inc. includes David Dean Halbert (CEO), Jeffrey Vacirca (CEO), Brian J. Brille (Chairman) and 6 others.

Luke Power on recent calls

“I'll move relatively quickly through the numbers since we have touched on some of them already. We delivered another strong quarter with total revenue of $275.4 million, which is up 27% year-over-year, and brings our nine-month revenue to $755.2 million, which is up 45% year-to-date.”
CFO, Caris Third Quarter 2026 Financial Results Conference Call ·
“Turning to slide 18 and I'll be brief, as David and Brian touched on some of these highlights earlier, we again delivered another strong quarter with total revenue of 263.7 million, up 45% year-over-year.”
CFO, Caris Second Quarter 2026 Financial Results Conference Call ·
“I'll go through this relatively quickly. All the numbers here have been disclosed publicly. So I think everyone's aware of these. But we continue to have strong revenue performance.”
CFO, Goldman Sachs Annual Global Healthcare Conference ·
“I'm actually going to be there on Friday again for yet another one.”
CFO, Bank of America Securities Health Care Conference ·
“As Brian stated earlier, we had another outstanding quarter in terms of financial performance. so I'll run through some selected highlights prior to getting to the 2026 guidance.”
CFO, Caris Life Sciences, Inc. Q4 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Caris Life Sciences, Inc.

Recent activity